RASAGILIN-TANNAT

European patent · EP2101570 · Deleted

Register entry

Publication number
EP2101570
Application number
EP07867741
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 13, 2007
Published
Sep 23, 2009
Granted
Feb 13, 2013
Deleted
Dec 31, 2016
Reason
Annual fee unpaid
IPC classes
C07C 211/42 (2006.01)
C07H 13/08 (2006.01)
Priority
US 875038 P 14.12.2006
PCT application
PCT/US2007/025516 13.12.2007
PCT publication
WO2008/076315 26.06.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 19, 2017

    Deleted, fee unpaid

    Published in Swissreg on 19.07.2017

  2. May 25, 2013

    Agent entered

    Representative
    Bugnion S.A., Case postale 375, 1211 Genève 12 - Champel

    Published in Swissreg on 25.05.2013

  3. Feb 13, 2013

    Granted

    Published in Swissreg on 13.02.2013

Parties

Holder

Teva Pharmaceutical Industries Ltd.

TEVA PHARMACEUTICAL INDUSTRIES, LTD.

5 Basel Street, P.O. Box 3190, 49131 Petach-Tikva, IL

Agent

Bugnion SA

Bugnion S.A.

Case postale 375, 1211 Genève 12 - Champel

Inventor

FRENKEL, Anton

42268 Netanya, IL

KOLTAI, Tamas

42758 Netanya, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.